Tuberculosis remains the leading infectious cause of mortality worldwide with ~10 million people who develop active disease each year. There remains an incomplete lack of understanding the TB pathogenesis and immunology, and the existing BCG vaccine is ineffective for preventing TB disease. In addition, many of the current diagnostic tests are inaccurate, and anti-tuberculosis drugs remain sub-optimal requiring lengthy treatment duration with many harmful side effects.
The University of Washington Advanced TB Research Training Course will cover diverse topic in TB research, including the current understanding of TB pathophysiology, diagnostics, therapeutics and prevention, immunology and vaccine development, transmission dynamics, implementation science, and disease modeling. In addition, the course will cover special topics, including TB maternal and child health and people living with HIV.
Participants will develop knowledge and skills in both theory and methods for advancing TB research. Participants will learn from case studies, lectures, panel discussions, and interactions with attendees and faculty. Finally, participants will engage in active learning opportunities to develop a hierarchical priority list and research plan to help advance tuberculosis research.
Course Sponsors: Bill & Melinda Gates Foundation, University of Washington Tuberculosis Research and Training Center.
